Bladder Cancer Clinical Trial

Study of Outcomes After Surgery/Treatment to Treat Bladder Cancer

Summary

The purpose of this study is to create a registry of older patients undergoing surgical and/or medical treatment for bladder cancer. The registry will record side-effect and outcomes related to the treatment using different surveys and biological measures.

View Full Description

Full Description

The primary purpose of this protocol is to create a registry of elderly patients with high-risk invasive bladder cancer undergoing radical cystectomy with or without preoperative chemotherapy.

Secondary objectives will include an exploration of the association between functional status, surgical complications, and laboratory markers with complications and survival. In addition, exploratory analyses may evaluate the association of expression of the senescence marker p16INK4a and the morbidity and mortality associated with treatment.

Patients will be asked to complete a Geriatric Assessment (GA) and FACT-Bl serially over the course of the study in order to evaluate their functional status and quality of life during the course of treatment. Additionally, complications will be tracked in an inpatient and outpatient setting using the Memorial Sloan Kettering Cancer Center (MSKCC) complications grading system.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Patients with a known pathologic diagnosis of lower tract urothelial carcinoma who are eligible to undergo radical cystectomy with or without neoadjuvant chemotherapy for definitive diagnosis and treatment.
Signed, IRB approved written informed consent.
Completion of baseline Geriatric Assessment

Exclusion Criteria:

Inability to read and speak English
Inability to comply with study for any other reason than language
Dementia, altered mental status, or any psychiatric condition that would prohibit the understanding or rendering of informed consent.

Study is for people with:

Bladder Cancer

Estimated Enrollment:

103

Study ID:

NCT01776138

Recruitment Status:

Completed

Sponsor:

UNC Lineberger Comprehensive Cancer Center

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

UNC Lineberger Comprehensive Cancer Center
Chapel Hill North Carolina, 27514, United States

How clear is this clinincal trial information?

Study is for people with:

Bladder Cancer

Estimated Enrollment:

103

Study ID:

NCT01776138

Recruitment Status:

Completed

Sponsor:


UNC Lineberger Comprehensive Cancer Center

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider